NCT06645314View on ClinicalTrials.gov

Study on the Safety and Efficacy of BST06 Injection in the Treatment of Advanced Hepatocellular Carcinoma

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2027

Conditions
Hepatocellular Carcinoma
Interventions
BIOLOGICAL

Group A

3.0 × 10 \^ 9 BST06 cells, intravenous infusion，at least 2 subjects enrolled, up to a maximum of 8 subjects enrolled

BIOLOGICAL

Group B

3.0 × 10 \^ 10 BST06 cells, intravenous infusion, at least 2 subjects enrolled, up to a maximum of 8 subjects enrolled

All Listed Sponsors
collaborator

South China Hospital of Shenzhen University

UNKNOWN

lead

BioSyngen Pte Ltd

INDUSTRY